With interest we read the article by Manganotti et al. about five COVID-19 patients who developed Guillain-Barre syndrome (GBS) 14-33 days after onset of the viral infection. This article is […]
Read More
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
